Similar articles

• Isotretinoin prescribing: finding a balance between benefit and risk.

  Stern RS. Stern RS. Pharmacoepidemiol Drug Saf. 2005 Sep;14(9):611-3. doi: 10.1002/pds.1145. Pharmacoepidemiol Drug Saf. 2005. PMID: 16134100 No abstract available.
• Roche responds to 'new warnings on the use of isotretinoin (Roaccutane)'.

  Ebrahim O, Bredenhann M. Ebrahim O, et al. S Afr Med J. 1999 Jan;89(1):16. S Afr Med J. 1999. PMID: 10070397 No abstract available.
• How to ensure fetal safety when mothers use isotretinoin (Accutane).

  Koren G, Pastuszak A. Koren G, et al. Can Fam Physician. 1997 Feb;43:216-9. Can Fam Physician. 1997. PMID: 9040906 Free PMC article. Review. No abstract available.
• Ethical and legal aspects of teratogenic medications: the case of isotretinoin.

  Moskop JC, Smith ML, De Ville K. Moskop JC, et al. J Clin Ethics. 1997 Fall;8(3):264-78. J Clin Ethics. 1997. PMID: 9436085 Review. No abstract available.
• The role of isotretinoin in the treatment of acne: personal observations.

  Leyden JJ. Leyden JJ. J Am Acad Dermatol. 1998 Aug;39(2 Pt 3):S45-9. doi: 10.1016/s0190-9622(98)70444-x. J Am Acad Dermatol. 1998. PMID: 9703123 Review. No abstract available.